Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA from Pharmacy Times - Journalist Profile

	Profile	Recent Articles on Subject
1	Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA Pharmacy Times	Advocacy in Action: Opportunities for Oncology Pharmacists in 2025 - about 1 month ago Final Thoughts - 2 months ago Personalizing Treatments and Patient Education - 3 months ago Pharmacists’ Roles on the Multidisciplinary Team - 3 months ago Pharmacists’ Roles in MM Management - 3 months ago SC vs IV Administration Methods - 3 months ago Impact of SC Daratumumab - 3 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 3 months ago Challenges in Adopting Novel Therapies - 4 months ago Real-World Considerations for New Therapies - 4 months ago Treatment Regimen Considerations - 4 months ago Impact of Transplant Eligibility on Treatment Selection - 4 months ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - 2 months ago Personalizing Treatments and Patient Education - 3 months ago Pharmacists’ Roles on the Multidisciplinary Team - 3 months ago Pharmacists’ Roles in MM Management - 3 months ago SC vs IV Administration Methods - 3 months ago Impact of SC Daratumumab - 3 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 3 months ago Challenges in Adopting Novel Therapies - 4 months ago Real-World Considerations for New Therapies - 4 months ago Treatment Regimen Considerations - 4 months ago Impact of Transplant Eligibility on Treatment Selection - 4 months ago
3	Brooke Adams, PharmD, BCOP Pharmacy Times	Final Thoughts - 2 months ago Personalizing Treatments and Patient Education - 3 months ago Pharmacists’ Roles on the Multidisciplinary Team - 3 months ago Pharmacists’ Roles in MM Management - 3 months ago SC vs IV Administration Methods - 3 months ago Impact of SC Daratumumab - 3 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 3 months ago Challenges in Adopting Novel Therapies - 4 months ago Real-World Considerations for New Therapies - 4 months ago Treatment Regimen Considerations - 4 months ago Impact of Transplant Eligibility on Treatment Selection - 4 months ago